REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,578,796 | -68.2% | 35,100 | -71.7% | 0.01% | -54.2% |
| Q1 2023 | $11,264,988 | +2547.5% | 123,900 | +1006.2% | 0.02% | +1100.0% |
| Q4 2022 | $425,488 | -49.6% | 11,200 | -66.7% | 0.00% | 0.0% |
| Q3 2022 | $844,000 | +54.6% | 33,600 | +87.2% | 0.00% | -33.3% |
| Q2 2022 | $546,000 | +107.6% | 17,951 | +80.1% | 0.00% | +200.0% |
| Q4 2021 | $263,000 | -56.5% | 9,965 | +66.1% | 0.00% | -66.7% |
| Q3 2021 | $604,000 | +150.6% | 6,000 | +252.9% | 0.00% | +200.0% |
| Q2 2021 | $241,000 | -14.8% | 1,700 | -41.4% | 0.00% | -50.0% |
| Q3 2020 | $283,000 | +20.9% | 2,900 | +93.3% | 0.00% | 0.0% |
| Q2 2020 | $234,000 | +11.4% | 1,500 | +2.9% | 0.00% | +100.0% |
| Q1 2020 | $210,000 | -93.8% | 1,458 | -91.2% | 0.00% | -95.7% |
| Q4 2019 | $3,373,000 | +855.5% | 16,500 | +275.5% | 0.02% | +1050.0% |
| Q3 2019 | $353,000 | +67.3% | 4,394 | +96.2% | 0.00% | 0.0% |
| Q2 2019 | $211,000 | -12.1% | 2,240 | -20.3% | 0.00% | +100.0% |
| Q1 2019 | $240,000 | +12.7% | 2,811 | -26.0% | 0.00% | -50.0% |
| Q4 2018 | $213,000 | -16.1% | 3,800 | +22.6% | 0.00% | +100.0% |
| Q3 2018 | $254,000 | +10.4% | 3,100 | -53.0% | 0.00% | 0.0% |
| Q2 2018 | $230,000 | +11400.0% | 6,592 | +6492.0% | 0.00% | – |
| Q1 2017 | $2,000 | -95.8% | 100 | -95.5% | 0.00% | – |
| Q4 2016 | $48,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $94,902,000 | 15.92% |
| Opaleye Management Inc. | 407,002 | $13,333,000 | 4.14% |
| Ikarian Capital, LLC | 649,600 | $21,281,000 | 2.80% |
| AWH Capital, L.P. | 150,000 | $2,459,457 | 2.54% |
| Boxer Capital, LLC | 1,239,000 | $40,590,000 | 2.09% |
| EcoR1 Capital, LLC | 1,975,611 | $64,721,000 | 2.02% |
| Camber Capital Management LP | 1,500,000 | $49,140,000 | 1.78% |
| MPM BioImpact LLC | 180,000 | $5,897,000 | 1.58% |
| Sofinnova Investments, Inc. | 602,545 | $19,739,000 | 1.50% |
| KRS Capital Management, LLC | 28,141 | $921,000 | 1.00% |